Message: FEATURE: Predictmedix - Preparing for the Next Stages of COVID-19 and Impairment Challenges in the Workplace

FEATURE: Predictmedix - Preparing for the Next Stages of COVID-19 and Impairment Challenges in the Workplace

posted on Oct 20, 2021 09:32AM
October 20, 2021 - Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF)
Reliable, quick, contactless, cost-effective screening solutions to bring safety to your workplace.

Preparing for the Next Stages of COVID-19 and Impairment Challenges in the Workplace


Safe Entry Stations

Mitigate risks to your team and to the uninterrupted operation of your business by setting up Safe Entry Stations for infectious disease symptom detection or for impairment detection. Our screening products are quick, noninvasive, no-contact solutions that can detect indication of symptoms. 

All it takes is a simple walk-through.

Safe Entry Station featured on Global News TV

(Oct 13/2021)

“We are happy to have Safe Entry Stations in our buildings. This form of high volume symptom screening has added an innovative tool to our properties, and offers peace of mind to our tenants and guests in these uncertain times.”
- R. Scott Hutcheson, Executive Chair, Aspen Properties
Necessity is the mother of invention. The current pandemic situation has changed lifestyle and daily routines even as people have become more aware of the need to take precautions to avoid contracting deadly diseases in crowded places.

The most stressful situation for most people has been the safety of their office space where co-workers and guests mill around with little social distancing. To meet this demand on new safety protocols Predictmedix has come out with an innovative AI-powered product to improve workplace health and safety, enhance protection in public and shared space environments, and provide tools for medical professionals to better care for patients.

Predictmedix is a life sciences technology company that is publicly traded on Canadian and US stock exchanges (PMED on CSE, and PMEDF on OTCQB). Their symptom detection products use non-invasive technologies to capture data points from each person walking through their Safe Entry screening units and determine within seconds when individuals are displaying symptoms of infectious disease, such as COVID-19.
Another of their screening products uses similar technology to determine when individuals are exhibiting signs of impairment from alcohol or cannabis. This is of particular value to companies with employees operating machinery or in positions where cognitive or physical performance is paramount for success and safety.
Safe Entry Stations are entirely customizable and can be retrofitted for permanent, temporary, or mobile applications. Additional AI products they currently have in development, such as the Mobilewellbeing remote patient care platform, will give medical professionals tools that empower their decision-making for better patient outcomes.

Symptom Detection Screening Solution for

Infectious Diseases

COVID-19 revealed how vulnerable our businesses and public spaces are to infectious diseases of any type. The current pandemic has brought public awareness about the importance of using a first-level screening tool where people gather in large groups. Employees are also increasingly demanding a safe and healthy work environment. Predictmedix’s Safe Entry Station is the first layer of risk mitigation to prevent the spread of contagious diseases such as COVID-19 at these locations. Notably, it is helping to facilitate the safe return of workers and customers for businesses and events around the world.
Even with vaccinations and countries loosening lock-down restrictions, increasing vaccinations and restarting their economies and societies, integrating a first layer of risk mitigation has been quite a task for corporates, governments and organizations. Predictmedix’s Safe Entry Station has gained currency for the fact that it can detect symptoms associated with the variants of the current pandemic, will be on guard for future waves, and will even detect influenza which alone has accounted for millions of people sick each year, millions wiped out in productivity, and sadly many lives lost.

Dr. Rahul Kushwah, COO of Predictmedix views Safe Entry Stations as the critical turning point to solving the primary infection transmission problem in the world. “Rather than rely only on people doing the right thing, let’s identify those individuals who are showing symptoms of infection before they mingle with others to spread infection and debilitate company operations, interrupt services or turn large events into a catastrophic health crisis.”

Symptom Detection Screening Solution for

Cannabis and Alcohol Impairment

Predictmedix’s product range has been keeping up with times. With legalization and increased use of cannabis occurring around the world, it has become imperative that employers have a cost-effective, quick and easy way to enforce safety at work. The increased liability risk for workers and the facility itself is now just too high to not have such a policy and solution in place.
Current research shows that levels (in blood or saliva) of THC, the most dominant psychoactive component of the cannabis plant, don’t function as reliable indicators for impairment. Breathalyzers are invasive and can’t detect all the different types of impairment. Our Safe Entry Stations are screening solutions, not testing solutions, so we can ensure safety by identifying impairment in real-time as individuals show up to work.”
This has become far more important since cannabis has been legalized for medicinal use in many parts of the world, with physicians prescribing cannabis for eating disorders, anxiety, cancer treatment relief and other uses that do not impact patients’ ability to perform at work. Predictmedix cannabis and alcohol impairment detection technology does not require any body fluids or human intervention, thereby helping to remove human error and the potential for discrimination and prejudice.
Employers are seeking a tool for the new environment in which cannabis is legal for both medical and especially recreational purposes. Dr. Rahul Kushwah commented, “We are looking for a way to differentiate between being under the influence and having something in your system.  We are not the moral police, but we absolutely do want to keep people safe while at work.”
“Implementing Safe Entry at our plants has dramatically decreased our absenteeism and increased employee peace of mind. Keeping our staff safe is top priority, and as such, we were determined to implement the best available solution, which we found in Safe Entry.”
- Nicholas Reichenbach, Founder & Executive Chairman, Flow Water Inc.
Designed by infectious disease experts, medical doctors, impairment specialists, and a global team of data scientists, and using a vast collection of continually updated real-world data, Predictmedix’s patent-pending screening is entirely autonomous and designed to protect the privacy of the end-user.
“The most interesting part is that Predictmedix focuses on AI solutions to problems that matter to all of us.”
- Kapil Raval, Advisor at Predictmedix,
Director of Artificial Intelligence Business Development, Microsoft

Partnered With

Safe Entry Stations are currently operating at many companies and events around the world.

Adopted By:

Completely unique to other solutions on the market, Predictmedix’s leading technology is changing the way we look at mass screening for infectious diseases and impairment. Safe Entry’s autonomous, comprehensive analysis provides peace of mind to individuals and businesses wherever people are entering shared spaces, be it for work or entertainment.

See How Safe Entry Works

Learn how the Safe Entry Station comprehensively screens without any contact.

About Predictmedix

Predictmedix (CSE:PMED) (OTCQB:PMEDFis an emerging provider of rapid health screening and remote patient care solutions globally. The Company’s Safe Entry Stations – powered by a proprietary artificial intelligence (AI) – use multispectral cameras to analyze physiological data patterns and predict a variety of health issues. The Company’s current product is able to screen for infectious diseases such as COVID-19, while its technology under development will screen for impairment by drugs or alcohol, or various mental illnesses. Predictmedix’s proprietary remote patient care platform under development will empower medical professionals with a suite of AI-powered tools to improve patient health outcomes. To learn more, please visit our website at or follow us on Twitter, Instagram or LinkedIn.

More Information

For further information please contact:

Investor Relations

Lucas A. Zimmerman

MZ Group – MZ North America

Phone:  949-259-4987
Email: [email protected]

Share this Article

Email to Friend

Was this article forwarded from a friend?

Looking for previous Market Summaries and Sponsored Articles?

Disclaimer: “The Company is not making any express or implied claims that its product has the ability to diagnose, eliminate, cure or contain the COVID-19 (or SARS-2 Coronavirus) at this time.”
New Message
Please login to post a reply